Myomo Inc Total Liabilities

Latest as of March 2026: $27.75 Million USD

Myomo Inc total liabilities. Based on the latest financial reports, Myomo Inc (MYO) has total liabilities worth $27.75 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MYO financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Myomo Inc (2014–2025)

Total liabilities of Myomo Inc from 2014 to 2025. This chart illustrates how Myomo Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Myomo Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Myomo Inc Competitors by Total Liabilities

The table below lists competitors of Myomo Inc ranked by their total liabilities.

Company Country Total Liabilities
SGA Solutions Co.Ltd
KQ:184230
Korea ₩94.61 Billion
Foods & Inns Limited
NSE:FOODSIN
India Rs7.35 Billion
Orbit Garant Drilling Inc.
TO:OGD
Canada CA$79.27 Million
NextSource Materials Inc
TO:NEXT
Canada CA$62.73 Million
Vishnu Prakash R Punglia Limited
NSE:VPRPL
India Rs12.39 Billion
GeneOne Life Science Inc
KO:011000
Korea ₩80.13 Billion
Velocity Minerals Ltd
V:VLC
Canada CA$26.61 Million
Grande Portage Resources Ltd
V:GPG
Canada CA$398.30K

Liability Composition Analysis (2014–2025)

This chart breaks down Myomo Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MYO total assets.

Liquidity & Leverage Metrics

Myomo Inc Total Liabilities Ratios Explained

Myomo Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.73 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.08 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.76 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Myomo Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Myomo Inc (2014–2025)

The table below shows the annual total liabilities of Myomo Inc from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 $27.23 Million +55.35%
2024-12-31 $17.53 Million +213.47%
2023-12-31 $5.59 Million +47.06%
2022-12-31 $3.80 Million -18.86%
2021-12-31 $4.69 Million +49.04%
2020-12-31 $3.14 Million -34.13%
2019-12-31 $4.77 Million +157.26%
2018-12-31 $1.86 Million +21.35%
2017-12-31 $1.53 Million -92.03%
2016-12-31 $19.19 Million +573.99%
2015-12-31 $2.85 Million +22.03%
2014-12-31 $2.33 Million --

About Myomo Inc

NYSE MKT:MYO USA Medical Devices
Market Cap
$40.18 Million
Market Cap Rank
#23251 Global
#5089 in USA
Share Price
$1.04
Change (1 day)
+9.47%
52-Week Range
$0.64 - $1.08
All Time High
$579.30
About

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more